ADVENTRX Pharmaceuticals (ANX) News

News for ADVENTRX Pharmaceuticals  (ANX) 
Sector News | Topic News
$ 0.715   -0.0056 (-0.78%) Volume: 602.36 k 4:00 PM EST Feb 10, 2012
After Hours:  $ 0.72   0.005 (+0.70%) Volume: 4.1 k 7:58 PM EST Feb 10, 2012
View News From:  
Tue, Feb 07, 2012
8:00 AM ADVENTRX Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference on February 14 - PR Newswire
Thu, Feb 02, 2012
9:15 AM Vista Partners Publishes February 2012 Newsletter - PR Newswire
Tue, Jan 31, 2012
8:20 AM Biotech Sector on the Upswing -- Dendreon and ADVENTRX Pharmaceuticals Looking Strong - Marketwire
Thu, Dec 15, 2011
9:15 AM Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price - PR Newswire
Thu, Dec 01, 2011
8:30 AM ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188 - PR Newswire
Wed, Nov 16, 2011
3:41 PM ADVENTRX Announces Closing of Public Offering - PR Newswire
Tue, Nov 15, 2011
8:16 AM Speculative Healthcare Companies IntelGenx and Adventrx Begin to Gain Ground - Marketwire
Fri, Nov 11, 2011
8:00 AM ADVENTRX Prices Public Offering of Stock - PR Newswire
Thu, Nov 10, 2011
4:28 PM ADVENTRX Announces Public Offering of Stock - PR Newswire
Mon, Nov 07, 2011
8:00 AM ADVENTRX Reports Third Quarter 2011 Financial Results - PR Newswire
Wed, Oct 26, 2011
8:16 AM Drug Approval Rate Stagnant -- Nektar and ADVENTRX Look to Defy Odds - Marketwire
8:00 AM ADVENTRX and FDA Reach Agreement on Pivotal Study for ANX-514 - PR Newswire
Wed, Oct 19, 2011
8:00 AM ADVENTRX Pharmaceuticals to Present at the 10th Annual BIOInvestor Forum Conference on October 26 - PR Newswire
Tue, Oct 04, 2011
8:16 AM ADVENTRX Pharmaceuticals and Cell Therapeutics Look Promising as Fourth Quarter Kicks Off - Marketwire
Fri, Sep 30, 2011
4:30 PM ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA - PR Newswire
Tue, Sep 13, 2011
8:16 AM Dendreon and ADVENTRX Spread Awareness in Hopes of Boosting Revenues - Marketwire
Fri, Sep 09, 2011
9:15 AM Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $7.50 Target Price - PR Newswire
Tue, Sep 06, 2011
8:00 AM ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12 - PR Newswire
Tue, Aug 30, 2011
8:00 AM ADVENTRX Provides Update on All Three Pipeline Products - PR Newswire
Fri, Aug 12, 2011
8:16 AM Big Pharma to Shift Focus to Biotech Firms Such as AEterna Zentaris and ADVENTRX - Marketwire
Tue, Jul 12, 2011
8:16 AM Dendreon and ADVENTRX Present Promising Pipelines - Marketwire
Wed, Jan 06, 2010
3:03 PM San Diego based ADVENTRX is subject of takeover rumors - Accesswire
Wed, Dec 23, 2009
11:01 AM Ichan's Adventrx Pharmaceuticals Ready To Run - Accesswire